Correlation Between Bio Gene and K2 Asset

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bio Gene and K2 Asset at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bio Gene and K2 Asset into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bio Gene Technology and K2 Asset Management, you can compare the effects of market volatilities on Bio Gene and K2 Asset and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bio Gene with a short position of K2 Asset. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bio Gene and K2 Asset.

Diversification Opportunities for Bio Gene and K2 Asset

-0.62
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Bio and KAM is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Bio Gene Technology and K2 Asset Management in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on K2 Asset Management and Bio Gene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bio Gene Technology are associated (or correlated) with K2 Asset. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of K2 Asset Management has no effect on the direction of Bio Gene i.e., Bio Gene and K2 Asset go up and down completely randomly.

Pair Corralation between Bio Gene and K2 Asset

Assuming the 90 days trading horizon Bio Gene Technology is expected to under-perform the K2 Asset. In addition to that, Bio Gene is 1.27 times more volatile than K2 Asset Management. It trades about -0.12 of its total potential returns per unit of risk. K2 Asset Management is currently generating about 0.37 per unit of volatility. If you would invest  5.00  in K2 Asset Management on September 1, 2024 and sell it today you would earn a total of  2.00  from holding K2 Asset Management or generate 40.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Bio Gene Technology  vs.  K2 Asset Management

 Performance 
       Timeline  
Bio Gene Technology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bio Gene Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Bio Gene is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
K2 Asset Management 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in K2 Asset Management are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain primary indicators, K2 Asset unveiled solid returns over the last few months and may actually be approaching a breakup point.

Bio Gene and K2 Asset Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bio Gene and K2 Asset

The main advantage of trading using opposite Bio Gene and K2 Asset positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bio Gene position performs unexpectedly, K2 Asset can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in K2 Asset will offset losses from the drop in K2 Asset's long position.
The idea behind Bio Gene Technology and K2 Asset Management pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges